3 results match your criteria: "Fetal Medicine and Genetics Centre[Affiliation]"
Evaluation of Fetal Heart Using Fetal Heart Quantification (fetalHQ) Technique in an Indian Cohort.
J Clin Ultrasound
October 2024
Fetal Medicine and Genetics Centre, Gurgaon, India.
Article Synopsis
- The study aimed to assess how consistently different operators can measure cardiac parameters using the FetalHQ software in Indian fetuses.
- Two operators analyzed 35 normal fetuses independently, and researchers calculated correlation coefficients to evaluate the reliability of the measurements.
- Results showed strong reliability for overall cardiac measurements but weaker correlations for specific strain metrics, indicating that while FetalHQ is useful, it still needs further improvements for accuracy, especially in regional contractility measurements.
Bright and enlarged fetal kidneys: One phenotype different genotypes, and counseling dilemmas.
J Clin Ultrasound
November 2024
Fetal Medicine and Genetics Centre, Gurgaon, India.
Article Synopsis
- * Researchers performed exome sequencing for four cases to identify genetic variants associated with the kidney abnormalities and found variants in the ACE, ETFA, PKD1, and MKS1 genes.
- * The authors emphasize that while exome sequencing is improving genetic diagnostics, understanding the implications of genetic variants requires collaboration among healthcare professionals to ensure timely and effective prenatal care.
Anti-G with Concomitant Anti-D and Anti-C in a Pre-natal Patient, in India: Multi-disciplinary Approach to Diagnosis and Management.
J Obstet Gynaecol India
December 2023
Department of Transfusion Medicine, Medanta-Gurugram, Sector-38, Gurgaon, 122001 India.
Article Synopsis
- The 'G' antigen, part of the Rh blood group system, was first identified in 1958 by researchers Allen and Tippet.
- It’s crucial to rule out anti-D antibodies in RhD-negative pregnant women before giving RhIg prophylaxis to avoid hemolytic disease of the fetus and newborn (HDFN).
- The report highlights the importance of identifying anti-G antibodies and utilizing a multidisciplinary team approach to manage HDFN through methods like intrauterine and exchange transfusions during the perinatal period.